NCT02310581View on ClinicalTrials.gov

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

PHASE3TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 24, 2015

Primary Completion Date

March 19, 2015

Study Completion Date

March 19, 2015

Conditions
Post-operative Pain
Interventions
DRUG

Buprenorphine Sublingual Spray

Buprenorphine sublingual spray delivered via single 100 μL spray

DRUG

Placebo

Placebo-matching buprenorphine sublingual spray delivered via single 100 μL spray

Trial Locations (3)

21122

Pasadena

78728

Austin

85027

Phoenix

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY